Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer
2006; Springer Science+Business Media; Volume: 25; Issue: 1 Linguagem: Inglês
10.1007/s10637-006-9008-5
ISSN1573-0646
AutoresJ S James, Daryl J. Murry, Anthony M. Treston, Anna Maria Storniolo, George W. Sledge, Carolyn Sidor, Kathy D. Miller,
Tópico(s)HER2/EGFR in Cancer Research
Referência(s)